Xiao‐Bing Zhang
Chinese Academy of Medical Sciences & Peking Union Medical College(CN)National Health and Family Planning Commission(CN)China Tobacco(CN)Naval University of Engineering(CN)Peking Union Medical College Hospital(CN)Institute of Hematology & Blood Diseases Hospital(CN)Shaoxing People's Hospital(CN)Tianjin Medical University(CN)
Publications by Year
Research Areas
CRISPR and Genetic Engineering, Pluripotent Stem Cells Research, Hematopoietic Stem Cell Transplantation, Mesenchymal stem cell research, Virus-based gene therapy research
Most-Cited Works
- → Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage(2017)484 cited
- → Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14(2010)430 cited
- → Clinically prevalent mutations in Mycobacterium tuberculosis alter propionate metabolism and mediate multidrug tolerance(2018)252 cited
- → Dynamics and competition of CRISPR–Cas9 ribonucleoproteins and AAV donor-mediated NHEJ, MMEJ and HDR editing(2020)185 cited
- → Highly efficient genome editing via CRISPR–Cas9 in human pluripotent stem cells is achieved by transient BCL-XL overexpression(2018)118 cited
- → High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vector(2008)107 cited